SML

Soni Medicare Share Price

₹42.00 +1.8 (4.48%)

05 Nov, 2024 21:52

SIP TrendupStart SIP in SML

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 28.83%
  • Over 3 Month + 53.51%
  • Over 6 Month + 55.67%
  • Over 1 Year + 62.92%
SIP Lightning

Smart Investing Starts Here Start SIP with Soni Medicare for Steady Growth!

Soni Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Soni Medicare Technicals

EMA & SMA

Current Price
₹42.00
+ 1.8 (4.48%)
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹35.79
  • 50 Day
  • ₹32.96
  • 100 Day
  • ₹30.82
  • 200 Day
  • ₹29.08

Resistance and Support

41.57 Pivot Speed
  • R3 44.03
  • R2 43.07
  • R1 42.53
  • S1 41.03
  • S2 40.07
  • S3 39.53

Is Soni Medicare Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

SML Isuzu Ltd. is a leading manufacturer of commercial vehicles in India, specializing in light and medium-duty trucks, as well as passenger vehicles. The company focuses on quality, innovation, and customer satisfaction, catering to diverse transportation needs. Sml Isuzu (Nse) has an operating revenue of Rs. 2,310.42 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 5% is okay, ROE of 37% is exceptional. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 157 indicates it belongs to a poor industry group of Auto Manufacturers and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Soni Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-14 Quarterly Results (Revised)
2023-08-14 Quarterly Results

Soni Medicare F&O

Soni Medicare Shareholding Pattern

43.96%
0.05%
0.35%
36.04%
19.6%
  • NSE Symbol
  • SML
  • BSE Symbol
  • 539378
  • Managing Director & CEO
  • Mr. Junya Yamanishi
  • ISIN
  • INE848R01018

Soni Medicare FAQs

Soni Medicare share price is ₹42 As on 05 November, 2024 | 21:38

The Market Cap of Soni Medicare is ₹17.9 Cr As on 05 November, 2024 | 21:38

The P/E ratio of Soni Medicare is -6.8 As on 05 November, 2024 | 21:38

The PB ratio of Soni Medicare is 11.1 As on 05 November, 2024 | 21:38

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form